Aquestive Therapeutics Inc (AQST)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 10.68M | 11.13M | 13.24M | 13M | 13.21M | 12.05M | 20.1M | 13.54M |
営業利益 | -10.71M | -4.61M | -4.21M | -2.38M | -3.91M | -8.96M | 55k | -8.29M |
税引前収入 | -12.35M | 8.07M | -5.51M | -2.18M | -8.01M | -12.83M | -2.75M | -11.51M |
純利益 | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -10.71M | -4.61M | -4.21M | -2.38M | -3.91M | -8.96M | 55k | -8.29M |
EBITDA | -10.32M | -4.28M | -3.92M | -2.11M | -3.44M | -8.75M | 260k | -8.13M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 51.79M | 66.92M | 67.43M | 52.61M | 45.85M | 50.83M | 47.68M | 50.58M |
営業利益 | -847k | -113k | -48.93M | -52.67M | -42.89M | -34.68M | -42.07M | -15.1M |
税引前収入 | -9.6M | -8.94M | -61.38M | -66.25M | -55.78M | -70.54M | -54.41M | -7.63M |
純利益 | -11.94M | -11.42M | -61.38M | -66.25M | -55.78M | -70.54M | -54.41M | -7.87M |
優先配当 | -2.34M | -2.48M | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.076 | -0.072 | -0.332 | -0.343 | -0.287 | -0.618 | -0.426 | -0.056 |
EBIT | -1.7M | -113k | -48.94M | -57.56M | -42.89M | -34.68M | -42.07M | -15.1M |
EBITDA | 3.04M | 3.69M | -45.7M | -49.76M | -39.45M | -31.72M | -39.68M | -13.76M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約